HALEIGH MARLOWE: Open Payments
NPI 1760147938 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 32 payments from 11 companies in 2025. Trend: 2023 $632 · 2024 $775 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $159 |
| UCB, Inc. | 7 | $148 |
| GENZYME CORPORATION | 3 | $76 |
| Janssen Biotech, Inc. | 3 | $72 |
| Lilly USA, LLC | 2 | $67 |
| Incyte Corporation | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| SANOFI US SERVICES INC. | 1 | $30 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| Botanix SB Inc | 1 | $20 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, TREMFYA, TALTZ, OPZELURA, Cabtreo, LIBTAYO.
Industry payments across WA — which companies pay providers there.
